CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,272 enrolled
Drug / intervention
Multicomponent Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03483662
NCT03483662N/ACompleted

Dissemination and Implementation of the SPRINT Study Findings in Underserved Populations

Tulane University·interventional·Posted Mar 30, 2018·Updated Jul 9, 2025

In Brief

A clinical study evaluating Multicomponent Intervention and Enhanced Usual Care for Hypertension and Blood Pressure. Completed, enrolled 1,272 participants across 2 sites.

Detailed Summary

The IMPACTS study utilizes an effectiveness-implementation hybrid type 2 design to achieve two primary goals simultaneously: 1). to test the effectiveness of a multifaceted implementation strategy for intensive BP control among underserved hypertensive patients at high risk for CVD, and 2). to assess the implementation outcomes of the multifaceted implementation strategy in patients and providers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 30, 2018
Enrollment StartJun 27, 2018
Primary CompletionFeb 15, 2024
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.3 years ago

Interventions

Multicomponent Interventionbehavioral

The core component of the intervention is protocol-based treatment using the SPRINT BP management algorithm. The following implementation strategies are adaptable components that will be modified to fit specific federally-qualified health center (FQHC) settings: dissemination of SPRINT study findings among provider-teams, patients, and administrators, team-based collaborative care, BP audit and feedback, home BP monitoring, and health coaching on antihypertensive medication adherence and lifestyle modification.

Enhanced Usual Carebehavioral

The investigators will provide an up-to-date clinical guideline for hypertension management to providers. A webinar education session on the new American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guideline and findings from the SPRINT trial will be conducted. Otherwise, the investigators will not conduct any active intervention and all control clinics will follow their routine clinic practice in the management of hypertensive patients